BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 23831388)

  • 21. [Blood-brain barrier and Alzheimer's disease].
    Kuwahara H; Nishida Y; Yokota T
    Brain Nerve; 2013 Feb; 65(2):145-51. PubMed ID: 23399672
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of Matrix Metallopeptidase 9 on Beta-Amyloid Elimination Across the Blood-Brain Barrier.
    Shackleton B; Ringland C; Abdullah L; Mullan M; Crawford F; Bachmeier C
    Mol Neurobiol; 2019 Dec; 56(12):8296-8305. PubMed ID: 31209784
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Magnesium Reduces Blood-Brain Barrier Permeability and Regulates Amyloid-β Transcytosis.
    Zhu D; Su Y; Fu B; Xu H
    Mol Neurobiol; 2018 Sep; 55(9):7118-7131. PubMed ID: 29383689
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antidiabetic drugs restore abnormal transport of amyloid-β across the blood-brain barrier and memory impairment in db/db mice.
    Chen F; Dong RR; Zhong KL; Ghosh A; Tang SS; Long Y; Hu M; Miao MX; Liao JM; Sun HB; Kong LY; Hong H
    Neuropharmacology; 2016 Feb; 101():123-36. PubMed ID: 26211973
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stimulation of the retinoid X receptor facilitates beta-amyloid clearance across the blood-brain barrier.
    Bachmeier C; Beaulieu-Abdelahad D; Crawford F; Mullan M; Paris D
    J Mol Neurosci; 2013 Feb; 49(2):270-6. PubMed ID: 22890420
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mixed oligomers and monomeric amyloid-β disrupts endothelial cells integrity and reduces monomeric amyloid-β transport across hCMEC/D3 cell line as an in vitro blood-brain barrier model.
    Qosa H; LeVine H; Keller JN; Kaddoumi A
    Biochim Biophys Acta; 2014 Sep; 1842(9):1806-15. PubMed ID: 24997450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ketone Bodies Promote Amyloid-β
    Versele R; Corsi M; Fuso A; Sevin E; Businaro R; Gosselet F; Fenart L; Candela P
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32023814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low levels of copper disrupt brain amyloid-β homeostasis by altering its production and clearance.
    Singh I; Sagare AP; Coma M; Perlmutter D; Gelein R; Bell RD; Deane RJ; Zhong E; Parisi M; Ciszewski J; Kasper RT; Deane R
    Proc Natl Acad Sci U S A; 2013 Sep; 110(36):14771-6. PubMed ID: 23959870
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apical-to-basolateral transport of amyloid-β peptides through blood-brain barrier cells is mediated by the receptor for advanced glycation end-products and is restricted by P-glycoprotein.
    Candela P; Gosselet F; Saint-Pol J; Sevin E; Boucau MC; Boulanger E; Cecchelli R; Fenart L
    J Alzheimers Dis; 2010; 22(3):849-59. PubMed ID: 20858979
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting ApoE4/ApoE receptor LRP1 in Alzheimer's disease.
    Martiskainen H; Haapasalo A; Kurkinen KM; Pihlajamäki J; Soininen H; Hiltunen M
    Expert Opin Ther Targets; 2013 Jul; 17(7):781-94. PubMed ID: 23573918
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interaction between intravenous immunoglobulin (IVIg) and the low-density lipoprotein receptor-related protein 1: a role for transcytosis across the blood brain barrier?
    Proulx DP; Rouleau P; Paré I; Vallières-Noël MM; Bazin R
    J Neuroimmunol; 2012 Oct; 251(1-2):39-44. PubMed ID: 22796178
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulatory effects of simvastatin and apoJ on APP processing and amyloid-β clearance in blood-brain barrier endothelial cells.
    Zandl-Lang M; Fanaee-Danesh E; Sun Y; Albrecher NM; Gali CC; Čančar I; Kober A; Tam-Amersdorfer C; Stracke A; Storck SM; Saeed A; Stefulj J; Pietrzik CU; Wilson MR; Björkhem I; Panzenboeck U
    Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Jan; 1863(1):40-60. PubMed ID: 28941799
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Method for measurement of the blood-brain barrier permeability in the perfused mouse brain: application to amyloid-beta peptide in wild type and Alzheimer's Tg2576 mice.
    LaRue B; Hogg E; Sagare A; Jovanovic S; Maness L; Maurer C; Deane R; Zlokovic BV
    J Neurosci Methods; 2004 Sep; 138(1-2):233-42. PubMed ID: 15325132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IgG-assisted age-dependent clearance of Alzheimer's amyloid beta peptide by the blood-brain barrier neonatal Fc receptor.
    Deane R; Sagare A; Hamm K; Parisi M; LaRue B; Guo H; Wu Z; Holtzman DM; Zlokovic BV
    J Neurosci; 2005 Dec; 25(50):11495-503. PubMed ID: 16354907
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mitogen-activated protein kinase signaling pathways promote low-density lipoprotein receptor-related protein 1-mediated internalization of beta-amyloid protein in primary cortical neurons.
    Yang WN; Ma KG; Qian YH; Zhang JS; Feng GF; Shi LL; Zhang ZC; Liu ZH
    Int J Biochem Cell Biol; 2015 Jul; 64():252-64. PubMed ID: 25936756
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amyloid-β concentration and structure influences the transport and immunomodulatory effects of IVIG.
    Wuest DM; Lee KH
    J Neurochem; 2014 Jul; 130(1):136-44. PubMed ID: 24517534
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LRP/amyloid beta-peptide interaction mediates differential brain efflux of Abeta isoforms.
    Deane R; Wu Z; Sagare A; Davis J; Du Yan S; Hamm K; Xu F; Parisi M; LaRue B; Hu HW; Spijkers P; Guo H; Song X; Lenting PJ; Van Nostrand WE; Zlokovic BV
    Neuron; 2004 Aug; 43(3):333-44. PubMed ID: 15294142
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bexarotene Promotes Cholesterol Efflux and Restricts Apical-to-Basolateral Transport of Amyloid-β Peptides in an In Vitro Model of the Human Blood-Brain Barrier.
    Kuntz M; Candela P; Saint-Pol J; Lamartinière Y; Boucau MC; Sevin E; Fenart L; Gosselet F
    J Alzheimers Dis; 2015; 48(3):849-62. PubMed ID: 26402114
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transport pathways for clearance of human Alzheimer's amyloid beta-peptide and apolipoproteins E and J in the mouse central nervous system.
    Bell RD; Sagare AP; Friedman AE; Bedi GS; Holtzman DM; Deane R; Zlokovic BV
    J Cereb Blood Flow Metab; 2007 May; 27(5):909-18. PubMed ID: 17077814
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clearance of amyloid-beta peptide across the blood-brain barrier: implication for therapies in Alzheimer's disease.
    Deane R; Bell RD; Sagare A; Zlokovic BV
    CNS Neurol Disord Drug Targets; 2009 Mar; 8(1):16-30. PubMed ID: 19275634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.